Home Our Speciality The Doctor Who We Help What To Expect Contact Us
Neuropsychology
1. What Is Neuropsychology
2. Neuropsychological Evaluation
3. Reason For Evaluation
4. Neuropsychological Treatment
Neuropsychological Conditions
Alzheimer's Disease & Other Dementias
Attention Deficit/ Hyperactivity Disorder
Brain Tumors & Cancer
Endocrine Disorders
Epilepsy & Seizure Disorders
Klinefelter Syndrome & Other Sex Chromosome Abnormalities
Learning Disorders: Reading (dyslexia), Math & Writing
Motor Neuron Diseases
Pervasive Developmental Disoders- Autism & Asperger's Disorder
Traumatic Brain Injury & Sports Concussion
Domain Assessed
Academic Achievement
Adaptive Functioning
Attention
Executive Functioning
Intellectual Functioning
Memory
Motor Speed & Coordination
Personality
Speech & Language
Visuoconstruction Abilities

NEWS

[2010-02-02]
Jrnl of Alzheimers Disease- Cigarette Smoking is a Risk Factor for Alzheimer’s Disease

Janine K. Cataldo, Judith J. Prochaska, Stanton A. Glantz
Cigarette Smoking is a Risk Factor for Alzheimer’s Disease: An Analysis Controlling for Tobacco Industry Affiliation
Abstract: To examine the relationship between smoking and Alzheimer’s disease (AD) after controlling for study design, quality, secular trend, and tobacco industry affiliation of the authors, electronic databases were searched; 43 individual studies met the inclusion criteria. For evidence of tobacco industry affiliation, http://legacy.library.ucsf.edu was searched. One fourth (11/43) of individual studies had tobacco-affiliated authors. Using random effects meta-analysis, 18 case control studies without tobacco industry affiliation yielded a non-significant pooled odds ratio of 0.91 (95% CI, 0.75-1.10), while 8 case control studies with tobacco industry affiliation yielded a significant pooled odds ratio of 0.86 (95% CI, 0.75-0.98) suggesting that smoking protects against AD. In contrast, 14 cohort studies without tobacco-industry affiliation yielded a significantly increased relative risk of AD of 1.45 (95% CI, 1.16-1.80) associated with smoking and the three cohort studies with tobacco industry affiliation yielded a non-significant pooled relative risk of 0.60 (95% CI 0.27-1.32). A multiple regression analysis showed that case-control studies tended to yield lower average risk estimates than cohort studies (by -0.27±0.15, P=0.075), lower risk estimates for studies done by authors affiliated with the tobacco industry (by -0.37±0.13, P=0.008), no effect of the quality of the journal in which the study was published (measured by impact factor, P=0.828), and increasing secular trend in risk estimates (0.031/year ±0.013, P=0.02). The average risk of AD for cohort studies without tobacco industry affiliation of average quality published in 2007 was estimated to be 1.72±0.19 (P<0.0005). The available data indicate that smoking is a significant risk factor for AD.

Evaluations for Adults

Adults request neuropsychological evaluations for ...
more

Evaluations for Children

In the majority of cases children are brought for ...
more

Lectures & Seminars

Dr. Rozenblatt is available for speaking engagemen...
more
Subscribe
Address
Shahal Rozenblatt, Ph.D.
Clinical Neuropsychologist
Advanced Psychological Assessment, P.C.

50 Karl Avenue, Suite 104
Smithtown, NY 11787

137 East 36 Street, Suite 4
New York, NY 10016

Tel: 866-840-9790
Site Index | Table of Contents | Links | Disclaimer

© 2006 Advancedpsy

neuro@advancedpsy.com | Legal Disclaimer | Notice of Privacy Practices

Partner